What to actually expect from anxiety medication

First-line, and why

For generalized anxiety, panic, and social anxiety, SSRIs and SNRIs are first-line across every major guideline. No single one is clearly superior, so the choice is matched to side-effect profile, any other conditions you have, cost, and your own preference. The FDA-approved options for generalized anxiety include escitalopram, paroxetine, duloxetine, and venlafaxine; for panic, sertraline and escitalopram tend to come out best when efficacy and tolerability are weighed together. Their effect on anxiety is real but gradual — which is the part most people aren't told, and the source of most disappointment.

The timeline that trips people up

Anxiolytic effects usually begin around 2 to 4 weeks and can take up to roughly 3 months to reach full benefit; early improvement in the first few weeks tends to predict later response. Because anxious bodies are unusually sensitive to early side effects that themselves feel like anxiety — jitteriness, a racing heart — the standard approach is deliberately "start low, go slow," with the dose raised in steps and each step given several weeks before it's judged. Knowing this in advance is protective: the single most common reason anxiety medication "fails" is being stopped in week one or two, before it ever had a chance to work.

Why benzodiazepines aren't first-line

Benzodiazepines (alprazolam, clonazepam, lorazepam) work within an hour — which is exactly why they're risky as an ongoing answer. Guidelines, and an FDA boxed warning, limit them to short-term, adjunctive use — generally no more than a few weeks, often while waiting for an SSRI to take hold. With sustained use, tolerance and physical dependence develop, withdrawal can be severe (rarely including seizures), long-term use is linked to cognitive effects that can persist after stopping, and in older adults to a meaningfully higher risk of falls and fractures. They are never recommended as a standalone anxiety treatment. One striking finding: in panic disorder, adding a benzodiazepine to exposure-based therapy adds no benefit and may actually blunt the fear-extinction learning that makes the therapy work.

The other options people rarely hear about

Between fast-but-risky benzodiazepines and slow-but-durable antidepressants sit a few alternatives. Buspirone, approved for generalized anxiety, carries no dependence, sedation, or withdrawal — but it works gradually like an antidepressant rather than on demand, and it tends to underwhelm people who've previously used benzodiazepines and expect that immediate calm; it's best as a second-line agent or an add-on. Hydroxyzine, an antihistamine, can take the edge off acute anxiety without dependence, but it's sedating and lacks strong long-term evidence. Neither is a cure-all; both are tools a careful prescriber reaches for in specific situations.

Therapy, and combining the two

Cognitive behavioral therapy works about as well as medication for anxiety, and its benefits last longer after treatment ends — a durability advantage medication doesn't share. For panic and generalized anxiety specifically, combining CBT with an antidepressant can outperform either alone, especially when a first treatment hasn't been enough. The honest summary: medication and therapy are both first-line, they work through different mechanisms, and the strongest results often come from using them together.

How long, and what success looks like

When an anxiety medication helps, guidelines generally suggest continuing it for at least 12 months before considering a slow, gradual taper — stopping early raises the risk of relapse. "Success" isn't the absence of all anxiety; it's anxiety brought down to a level that no longer runs your days, with side effects you can live with. Whether medication is right at all, which one, and for how long are individual clinical decisions made with you, not handed down — and revisited as you go.

Related service